jahresbericht 2012 - Biologische Psychiatrie - Medizinische ...

8059. Konstantinidis A, Kasper S (2012) Depression – neue therapeutische Optionen. ÄrzteWoche 6: 22 (IF: 0)60. Konstantinidis A, Kasper S (2012) Stottern induziert durch Psychopharmaka. CliniCumneuropsy 5: 28-29 (IF: 0)61. Konstantinidis A, Papageorgiou K, Grohmann R, Horvath A, Engel R, Kasper S (2012)Increase of antipsychotic medication in depressive inpatients from 2000 to 2007:Results from the AMSP International Pharmacovigilance Program. InternationalJournal of Neuropsychopharmacology 15 (4): 449-457 (IF: 4.699)62. Konstantinidis A, Stamenkovic M, Kasper S (2012) Krampfanfall unterKombinationsbehandlung. CliniCum neuropsy 1: 46-47 (IF: 0)63. Kranz G, Hahn A, Savli M, Lanzenberger R (2012) Challenges in the differentiation ofmidbrain raphe nuclei in neuroimaging research. Proceedings of the National Academyof Sciences 109 (29): E2000 (IF: 9.681)64. Kraus C, Hahn A, Savli M, Kranz G, Baldinger P, Höflich A, Spindelegger C,Ungersboeck J, Haeusler D, Mitterhauser M, Windischberger C, Wadsak W, Kasper S,Lanzenberger R (2012) Serotonin 1A receptor binding is positively is associated withgray matter volume - a multimodal neuroimaing study cmbining PET and structuralMRI. Neuroimage 63 (3): 1091-1098 (IF: 5.895)65. Lakeman R, McGowan P, MacGabhann L, Parkinson M, Redmond M, Sibitz I,Stevenson C, Walsh J (2012) A qualitative study exploring experiences ofdiscrimination associated with mental-health problems in Ireland. Epidemiology andPsychiatric Sciences 21(3): 271-279 (IF: 0)66. Lanzenberger R, Kranz G, Häusler D, Akimova E, Savli M, Hahn A, Wadsak W,Spindelegger C, Philippe C, Fink M, Mitterhauser M, Kasper S (2012) Prediction ofSSRI treatment response in major depression based on serotonin transporter interplaybetween median raphe nucleus and projection areas. NeuroImage 63 (2): 874-881 (IF:5.895)67. Letmaier M, Painold A, Holl AK, Vergin H, Engel R, Konstantinidis A, Kasper S,Grohmann R (2012) Hyponatremia during psychopharmacological treatment – a resultof a drug surveillance program. International Journal of Neuropsychopharmacology 15(6): 739-748 (IF: 4.699)68. Mark C, Bornatowicz B, Mitterhauser M, Hendl M, Nics L, Haeusler D, LanzenbergerR, Berger M, Spreitzer H, Wadsak W (2012) Development and automation of a novelNET-PET tracer: [11C]Me@APPI. Nuclear Medicine and Biology 40 (2): 295-303 (IF:3.023)69. Mendlewicz J, Crisafulli C, Calati R, Kocabas NA, Massat I, Linotte S, Kasper S, FinkM, Sidoti A, Scantamburlo G, Ansseau M, Antonijevic I, Forray C, Snyder L, Bollen J,Montgomery S, Zohar J, Serretti A (2012) Influence of COX-2 and OXTRpolymorphisms on treatment outcome in treatment resistant depression. NeuroscienceLetters 516 (1): 85-88 (IF: 2.105)